May 13th 2024
While urologists and oncologists agreed on many barriers and facilitators of first-line treatment intensification for metastatic castrate-sensitive prostate cancer, there were also a number of differing beliefs, including whether there is enough clinical support.
Community-Based Initiative Doubles Accrual Rate of Black Participants in Cancer Trials
June 9th 2021An initiative launched with the intent to deliver equitable cancer care improved the enrollment rates of Black participants in cancer clinical trials by focusing on community outreach and engagement.
Read More
ASCO’s Dr Lori Pierce on Equity in Cancer Care: “History Has Its Eyes on Us”
June 5th 2021Equality in cancer care is not sufficient, said Lori Pierce, MD, FASTRO, FASCO, a radiation oncologist from the University of Michigan and president of the American Society of Clinical Oncology (ASCO). Equity—which means that patients have similar outcomes, regardless of circumstance—is harder to achieve.
Read More
Contributor: Maintaining the Doctor-Patient Connection During the COVID-19 Pandemic
May 29th 2021Christine Ko, MD, professor of dermatology and pathology at Yale University, reflects on her use of telehealth and how it allowed her to establish and maintain emotional connections with her patients, all at high risk of skin cancer.
Read More
Oncology Roundup: Long-term Risks for Survivors, COVID-19 Accommodation Longevity, and More
May 24th 2021Some recent oncology news includes research into factors impacting the well-being of childhood cancer survivors; whether COVID-19 accommodations will last post-pandemic; and a possible new therapy for patients with polycythemia vera.
Read More
Review Highlights Sociodemographic Disparities in Cancer Risk Factors and Prevention Measures
May 22nd 2021A literature review sheds light on cancer risk factors and suboptimal screening levels that persist in the United States among certain racial, ethnic, and socioeconomic groups, despite a steady decline in cancer deaths and smoking prevalence.
Read More
Lack of Information on Cancer Type in Attribution Algorithms Yields Variations, Inaccurate Results
May 13th 2021Attribution algorithms for patients with newly diagnosed cancer should account for cancer type and stage, among other characteristics, to ensure that attribution measurements are accurately calculated, investigators concluded.
Read More
Oncology Value Coalition: Disparities in Cancer Care—Sources and Solutions, Part 3
April 22nd 2021In the inaugural Oncology Value Coalition from The American Journal of Managed Care®, Kashyap Patel, MD, led a discussion with Debra Patt, MD, PhD, MBA; and Karen Winkfield, MD, PhD, exploring findings that suggest minority groups develop cancer at higher rates and experience worse outcomes than nonminority groups.
Read More
Oncology Value Coalition: Disparities in Cancer Care—Sources and Solutions, Part 2
April 22nd 2021In the inaugural Oncology Value Coalition from The American Journal of Managed Care®, Kashyap Patel, MD, led a discussion with Debra Patt, MD, PhD, MBA; and Karen Winkfield, MD, PhD, exploring findings that suggest minority groups develop cancer at higher rates and experience worse outcomes than nonminority groups.
Read More
Oncology Value Coalition: Disparities in Cancer Care—Sources and Solutions, Part 1
April 22nd 2021In the inaugural Oncology Value Coalition from The American Journal of Managed Care®, Kashyap Patel, MD, led a discussion with Debra Patt, MD, PhD, MBA; and Karen Winkfield, MD, PhD, exploring findings that suggest minority groups develop cancer at higher rates and experience worse outcomes than nonminority groups.
Read More
Treatment Patterns for Patients With Advanced/Metastatic Cancers by Site of Care
Treatment patterns and overall survival were similar regardless of site of care between patients receiving anticancer therapy in the hospital outpatient vs physician office setting.
Read More